| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/29/2010 | WO2010047559A2 Sustained-release pharmaceutical formulations |
| 04/29/2010 | WO2010047381A1 Stable tablet containing 4,5-epoxymorphinan derivative |
| 04/29/2010 | WO2010047302A1 Combination nutritional infusion |
| 04/29/2010 | WO2010047108A1 Calicivirus inactivation method |
| 04/29/2010 | WO2010046917A2 Fludarabine phosphate composition |
| 04/29/2010 | WO2010046861A1 Composition for treatment of epithelial tissue |
| 04/29/2010 | WO2010046726A1 Xylitol esters and ethers applied as alternative emulsifiers, solvents, co-emulsifiers and preservative systems for pharmaceutical and cosmetic products |
| 04/29/2010 | WO2010046681A1 Nanoparticles |
| 04/29/2010 | WO2010046583A1 Microcapsules having an envelope composed essentially of silsesquioxane homopolymers or copolymers |
| 04/29/2010 | WO2010046418A1 Pharmaceutical composition comprising levetiracetam |
| 04/29/2010 | WO2010046338A1 Composition for targeting dendritic cells |
| 04/29/2010 | WO2010045788A1 A orally disintegrating tablet of donepezil hydrochloride and the preparation method thereof |
| 04/29/2010 | WO2010045755A1 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 04/29/2010 | WO2010045739A1 Process of producing directly compressed tablets of sterols and/or stanols |
| 04/29/2010 | WO2010045700A1 Method for preparing a veterinary suspension formulation for administering water-insoluble medicaments |
| 04/29/2010 | WO2010027405A3 Formulations of gc-c receptor agonist polypeptides |
| 04/29/2010 | WO2010022031A8 Topical hydrogel composition |
| 04/29/2010 | WO2010017948A3 Pharmaceutical compositions of rivaroxaban with modified release properties |
| 04/29/2010 | WO2010014827A3 Formulations containing large-size carrier particles for dry powder inhalation aerosols |
| 04/29/2010 | WO2010011609A3 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 04/29/2010 | WO2010011597A3 Treatment of obesity and related disorders |
| 04/29/2010 | WO2010011541A3 Topical anti-inflammatory combination |
| 04/29/2010 | WO2010007232A4 Novel rapid-effect pharmaceutical forms and uses of resulting pharmaceutical compositions |
| 04/29/2010 | WO2010006753A3 Silicon dioxide nanoparticles and their use for vaccination |
| 04/29/2010 | WO2009108077A3 Pharmaceutical composition for poorly soluble drugs |
| 04/29/2010 | WO2009037319A3 Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine |
| 04/29/2010 | WO2009034453A4 Method for the immobilization of bioactive molecules within a polymeric substrate resistant to the stomach acids as oral drug delivery system |
| 04/29/2010 | WO2009011449A3 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 04/29/2010 | US20100106233 Bionanocomposite for tissue regeneration and soft tissue repair |
| 04/29/2010 | US20100105946 Hydrolytically Degradable Carbamate Derivatives of Poly(Ethylene Glycol) |
| 04/29/2010 | US20100105870 Method Of Complexing A Protein By The Use Of A Dispersed System And Proteins Thereof |
| 04/29/2010 | US20100105649 Veterinary compositions for treating mastitis |
| 04/29/2010 | US20100105107 Purification and characterization of soluble mhc proteins |
| 04/29/2010 | US20100104656 Meltable Binder for Melt Granulation and/or Pelletization |
| 04/29/2010 | US20100104655 Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same |
| 04/29/2010 | US20100104654 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 04/29/2010 | US20100104653 Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease |
| 04/29/2010 | US20100104652 Use of advanced nanomaterials for increasing sepecific cell functions |
| 04/29/2010 | US20100104651 Pharmaceutical Compositions Containing Diacerein |
| 04/29/2010 | US20100104650 Charged mesoporous silica nanoparticle-based drug delivery system for controlled release and enhanced bioavailability |
| 04/29/2010 | US20100104649 Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate |
| 04/29/2010 | US20100104648 Treatment of inflammatory and/or bacterial conditions with particles of microstructure |
| 04/29/2010 | US20100104647 Hollow microparticles |
| 04/29/2010 | US20100104646 Nanoparticle composition for prevention of hair loss and promotion of hair growth |
| 04/29/2010 | US20100104645 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles |
| 04/29/2010 | US20100104644 Compositions and Methods for Treating or Preventing Ophthalmic Disease |
| 04/29/2010 | US20100104643 Pharmaceutical compositions |
| 04/29/2010 | US20100104642 Hydrophilic foam and pharmaceutical dosage form employing the same |
| 04/29/2010 | US20100104640 Pharmaceutical compositions comprising irbesartan |
| 04/29/2010 | US20100104639 Bupropion hydrobromide and therapeutic applications |
| 04/29/2010 | US20100104638 Extended release oral acetaminophen/tramadol dosage form |
| 04/29/2010 | US20100104637 Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 04/29/2010 | US20100104636 Pharmaceutical Compound and Composition |
| 04/29/2010 | US20100104635 Process for preparing granules of hydrophilic vitamins |
| 04/29/2010 | US20100104634 Pharmaceutical compositions of entacapone |
| 04/29/2010 | US20100104633 antifungal formulations comprising terbinafine or a pharmaceutically acceptable salt thereof, a lipid, and a surfactant; uses thereof for the treatment of skin and nail fungal infections |
| 04/29/2010 | US20100104632 Drug Having Regulatory Cell Ligand Contained in Liposome |
| 04/29/2010 | US20100104631 Method of treatment for bladder dysfunction |
| 04/29/2010 | US20100104630 Water soluble statin microstructures and method of preparation |
| 04/29/2010 | US20100104629 Cationic lipids and uses thereof |
| 04/29/2010 | US20100104628 method of treating neuroblastoma |
| 04/29/2010 | US20100104627 Stable aqueous g-csf formulations |
| 04/29/2010 | US20100104626 Methods and compositions for treating and diagnosing kidney disease |
| 04/29/2010 | US20100104625 Biodegradable compositions and materials |
| 04/29/2010 | US20100104624 Combination therapy using phosphodiesterase inhibitors |
| 04/29/2010 | US20100104623 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent |
| 04/29/2010 | US20100104622 Ligand Targeted Nanocapsules for the delivery of RNAi and other Agents |
| 04/29/2010 | US20100104621 Treating adhd and other diseases involving inflammation |
| 04/29/2010 | US20100104620 Over-coated product including tableted center and medicament |
| 04/29/2010 | US20100104619 Delivery system for a non-steroidal non-ionized hydrophilic drug |
| 04/29/2010 | US20100104618 Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use |
| 04/29/2010 | US20100104614 Providone compositions for wound healing |
| 04/29/2010 | US20100104611 Antiperspirant compositions |
| 04/29/2010 | US20100104608 Reactive surgical implant |
| 04/29/2010 | US20100104607 Anti-bacterial peptides and methods of treating diseases using same |
| 04/29/2010 | US20100104518 Chewing gum, confection, and other oral delivery vehicles containing a traditional chinese medicine or extract thereof |
| 04/29/2010 | US20100104517 Anhydrous Antiperspirant Compositions |
| 04/29/2010 | US20100104516 Use of flagellin to prevent and treat gram negative bacterial infection |
| 04/29/2010 | US20100104515 Use of alpha-hydroxy carbonyl compounds as reducing agents |
| 04/29/2010 | US20100104507 Use of sterically stabilized cationic liposomes to efficiently deliver cpg oligonucleotides in vivo |
| 04/29/2010 | US20100104506 Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease |
| 04/29/2010 | US20100102474 Method for preparing sustained release tablet |
| 04/29/2010 | DE19823940B4 Enterische Fluoxetinpellets Enteric Fluoxetinpellets |
| 04/29/2010 | DE102008053044A1 Composition, useful for preventing and/or treating renal dysfunction, preferably renal failure, comprises combination of calcium salt as first active component, and magnesium salt, as second active component |
| 04/29/2010 | DE102008052620A1 Device, useful for continuous biophysical information transfer and storage, comprises a device for delivering input frequency spectrum of untreated aqueous solution, a processing section with treatment steps and a signal generating device |
| 04/29/2010 | DE10085492B4 Antimonocytenaktivität von extrakten von Betelpfefferblättern Antimonocytenaktivität of extracts of Betelpfefferblättern |
| 04/29/2010 | CA2751761A1 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 04/29/2010 | CA2742047A1 Compositions and methods for promoting bone formation |
| 04/29/2010 | CA2741368A1 Compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4h-1,2,4-triazol-3-ylthio) acetamido)-3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| 04/29/2010 | CA2741252A1 Drug delivery systems and methods for treating neovascularization |
| 04/29/2010 | CA2741028A1 Composition for treatment of epithelial tissue |
| 04/29/2010 | CA2740857A1 Composition for targeting dendritic cells |
| 04/29/2010 | CA2740476A1 Stable tablet containing 4,5-epoxymorphinan derivative |
| 04/29/2010 | CA2738683A1 Anhydrous antiperspirant compositions |
| 04/28/2010 | EP2180027A1 Novel lipid-tripeptide based hydrogel-forming agent and hydrogel |
| 04/28/2010 | EP2179736A1 Two-component eye drops containing pirenoxine |
| 04/28/2010 | EP2179731A1 Amino-acid-containing medicinal granular preparation highly easy to take |
| 04/28/2010 | EP2179729A1 Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen |
| 04/28/2010 | EP2179728A1 Non-gelatin shell material of hard capsule and process for preparing thereof |
| 04/28/2010 | EP2179727A1 Water insoluble polymer : modified starch derivative-based film coatings for colon targeting |